Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Slavin

Showing results (381-390 of 436) with videos related to

Pageof 44
Sort By:
Annals of Surgery|February 1, 1981
Kidney allograft survival in dogs treated with total lymphoid irradiationR J Howard, D E Sutherland, C T Lum, et al.
Israel Journal of Medical Sciences|March 1, 1986
New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantationS Slavin, R Or, E Naparstek, et al.
American Journal of Hematology|October 31, 2003
Rhinolalia as a presenting sign of pneumomediastinum complicating post peripheral blood stem cell transplantation bronchiolitis obliteransM Bitan, I B Resnick, R Or, et al.
Immunological Reviews|January 1, 1979
Immunobiology of a spontaneous murine B cell leukemia (BCL1)S Strober, E S Gronowicz, M R Knapp, et al.
The Journal of Clinical Investigation|August 1, 1993
Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantationD M Karussis, U Vourka-Karussis, D Lehmann, et al.
Bone Marrow Transplantation|November 13, 2007
Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemiaM Bitan, R Or, M Y Shapira, et al.
Transplantation Proceedings|February 1, 1989
The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disordersS Slavin, E Naparstek, M Aker, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2S Morecki, S Revel-Vilk, C Nabet, et al.
Journal of Pediatric Hematology/Oncology|April 17, 1998
Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia majorM Aker, J Kapelushnik, T Pugatsch, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibodyL Weiss, S Slavin, S Reich, et al.
Pageof 44

Showing results (381-390 of 436) with videos related to

Sort By:
Pageof 44
Annals of Surgery|February 1, 1981
Kidney allograft survival in dogs treated with total lymphoid irradiationR J Howard, D E Sutherland, C T Lum, et al.
Israel Journal of Medical Sciences|March 1, 1986
New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantationS Slavin, R Or, E Naparstek, et al.
American Journal of Hematology|October 31, 2003
Rhinolalia as a presenting sign of pneumomediastinum complicating post peripheral blood stem cell transplantation bronchiolitis obliteransM Bitan, I B Resnick, R Or, et al.
Immunological Reviews|January 1, 1979
Immunobiology of a spontaneous murine B cell leukemia (BCL1)S Strober, E S Gronowicz, M R Knapp, et al.
The Journal of Clinical Investigation|August 1, 1993
Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantationD M Karussis, U Vourka-Karussis, D Lehmann, et al.
Bone Marrow Transplantation|November 13, 2007
Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemiaM Bitan, R Or, M Y Shapira, et al.
Transplantation Proceedings|February 1, 1989
The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disordersS Slavin, E Naparstek, M Aker, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2S Morecki, S Revel-Vilk, C Nabet, et al.
Journal of Pediatric Hematology/Oncology|April 17, 1998
Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia majorM Aker, J Kapelushnik, T Pugatsch, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibodyL Weiss, S Slavin, S Reich, et al.
Pageof 44